Rare diseases
Investigational molecules
Locations
Back to Germany1 clinical trial in Arnsberg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hormone receptor-positive HER2-negative breast cancer are exploring innovative combination therapies. These studies aim to evaluate treatment effectiveness in patients with locally advanced or metastatic disease.
Research emphasizes personalized treatment approaches for different patient cohorts based on their prior treatment history and response patterns.
Investigations into endocrine therapy combinations are being conducted to improve outcomes for patients with advanced breast cancer. The research evaluates treatment effectiveness across different patient populations.
Studies incorporate modern digital technologies to enhance patient care and monitor treatment outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
